Emergence in Asian Countries of Staphylococcus aureus with Reduced Susceptibility to Vancomycin-Reference-Cited by-同舟云学术

Emergence in Asian Countries of Staphylococcus aureus with Reduced Susceptibility to Vancomycin

Published:2004-12 Issue:12 Volume:48 Page:4926-4928
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Song Jae-Hoon¹²,Hiramatsu Keiichi³,Suh Ji Yoeun²,Ko Kwan Soo²,Ito Teruyo³,Kapi Maria³,Kiem Sungmin¹,Kim Yeon-Sook⁴,Oh Won Sup¹,Peck Kyong Ran¹,Lee Nam Yong⁵

Affiliation:

1. Division of Infectious Diseases

2. Asian-Pacific Research Foundation for Infectious Diseases (ARFID), Seoul

3. Department of Bacteriology, Juntendo University, Tokyo, Japan

4. Chungnam National University Hospital, Daejon, South Korea

5. Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine

Abstract

ABSTRACT To investigate the prevalence of Staphylococcus aureus with reduced susceptibility to vancomycin among methicillin-resistant S. aureus (MRSA) strains in Asian countries, a total of 1,357 clinical isolates of MRSA collected from 12 Asian countries were screened by using brain heart infusion agar plates containing 4 mg of vancomycin per liter. The presence of strains that were heterointermediately resistant to vancomycin (hVISA) was confirmed by population analysis. Of 347 (25.6%) MRSA isolates that grew on the screening agar plates, 58 isolates (4.3%) were hVISA. hVISA strains were found in India, South Korea, Japan, the Philippines, Singapore, Thailand, and Vietnam. However, neither vancomycin-intermediate S. aureus nor vancomycin-resistant S. aureus isolates were found among MRSA isolates from Asian countries in this survey.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.48.12.4926-4928.2004

Reference20 articles.

1. Ariza, J., M. Pujol, C. Cabo, C. Peña, N. Fernándes, J. Liñares, J. Ayats, and F. Gudiol. 1999. Vancomycin in surgical infections due to methicillin-resistant Staphylococcal aureus with heterogeneous resistance to vancomycin. Lancet353:1587-1588.

2. Prevalence, Molecular Epidemiology, and Clinical Significance of Heterogeneous Glycopeptide-Intermediate Staphylococcus aureus in Liver Transplant Recipients

3. Bierbaum, G., K. Fuchs, W. Lenz, C. Szekat, and H. G. Sahl. 1999. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur. J. Clin. Microbiol. Infect. Dis.18:691-696.

4. Centers for Disease Control and Prevention. 2002. Staphylococcus aureus resistant to vancomycin—United States, 2002. Morb. Mortal. Wkly. Rep.51:565-567.

5. Centers for Disease Control and Prevention. 2002. Vancomycin-resistant Staphylococcus aureus—Pennsylvania, 2002. Morb. Mortal. Wkly. Rep.51:902.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global distribution of heterogeneous vancomycin-intermediate Staphylococcus aureus strains (1997–2021): a systematic review and meta-analysis;Journal of Global Antimicrobial Resistance;2024-06

2. Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia;Antibiotics;2023-05-27

3. Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (HVISA) at a Tertiary Hospital in Malaysia;Sains Malaysiana;2022-03-31

4. Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus among Methicillin-Resistant Staphylococcus aureus;Asian Journal of Pharmaceutical Research and Health Care;2022

5. A Thin Layer of Faeces on Everything You Touch;The End of an Antibiotic Era;2021